Engineered bacteria prime tumors for selective elimination

Engineered bacteria prime tumors for selective elimination: What if bacteria—which love to grow deep inside tumors—could guide cancer therapies directly to their target? NIH-funded researchers have engineered a bacterial strain to “light up” tumors so that reprogrammed T cells, drawn like a moth to a flame, can find and destroy them. Their preclinical treatment could potentially be effective against any solid tumor type.